执行董事及行政总裁张春光减持华康生物医学2.4万股 每股作价0.38港元

Group 1 - The core point of the article is that Zhang Chunguang, the Executive Director and CEO of Huakang Biomedical (08622), has reduced his shareholding by selling 24,000 shares at a price of HKD 0.38 per share, totaling approximately HKD 9,120 [1] - After the sale, Zhang's remaining shareholding is approximately 3.976 million shares, which represents a holding percentage of 0.77% [1]